Ocugen, Inc. (OCGN)
1.89
+0.07
(+3.85%)
USD |
NASDAQ |
Mar 02, 11:50
Ocugen Research and Development Expense (TTM) : 35.49M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| MannKind Corp. | 66.35M |
| CorMedix, Inc. | 12.46M |
| Alector, Inc. | 113.40M |
| Phathom Pharmaceuticals, Inc. | 32.78M |
| Keros Therapeutics, Inc. | 157.36M |